FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer (HealthDay)

HealthDay - WEDNESDAY, July 1 (HealthDay News) -- Despite recent studies suggesting that the injected diabetes drug Lantus (insulin glargine) might boost cancer risk, the U.S. Food and Drug Administration on Wednesday urged patients who are on the medication to continue using it.